- Corporate
- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Privacy policy
- Contact us
- Subscribe
- Thank you
- Error
The share
Stock Exchange listing
XVIVO is listed on Nasdaq Stockholm mid cap list. The share has been listed on Nasdaq Stockholm mid cap since November 28, 2016. The XVIVO share was before that listed on Nasdaq First North since October 8, 2012.
ISIN-code: SE0004840718
Ticker: XVIVO
Trading lot: 1 share
Stock chart
Stock table
Stock calculator
Dividend Table
2012 – Allotment of acquisition cost XVIVO decided by the Swedish Tax Agency.
In connection with Vitrolife’s distribution of the shares in XVIVO AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to XVIVO AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets allmanna rad (SKV A 2012-28)
Skatteverkets meddelande (SKV M 2012-25)
2016 – The Swedish Tax Agency decided how to tax the Vivoline shares purchased by XVIVO.
In connection with XVIVO´s acquisition of Vivoline Medical AB the Swedish Tax Agency decided the tax treatment for the Vivoline shares purchased by XVIVO AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets Brevsvar ang. XVIVOs köp av Aktier och Optioner i Vivoline